Click to go to DrugInjuryLaw Home

Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation

Free Case Evaluation

Yasmin And Yaz MDL (Multidistrict Litigation) Assigned To Judge David R. Herndon, Southern District of Illinois

MDL No. 2100: Consolidation Of All Yaz, Yasmin, And Ocella Lawsuits Alleging Personal Injury Or Wrongful Death That Are Filed In Federal Court System

On October 1, 2009 the United States Judicial Panel on Multidistrict Litigation (JPML) issued a Transfer Order which creates MDL No. 2100 -- IN RE: Yasmin and Yaz (Drospirenone) Marketing and Sales Practices and Products Liability Litigation.

By operation of this JPML Transfer Order, all Yaz, Yasmin, and Ocella personal injury and wrongful death cases filed in the federal court system will be consolidated into a Multidistrict Litigation, or MDL, with U.S. District Court Judge David R. Herndon presiding over these Yaz, Yasmin, and Ocella cases for "coordinated or consolidated pretrial proceedings".

From the October 2009 JPML Transfer Order for MDL No. 2100:

On the basis of the papers filed and hearing session held, we find that these 32 actions involve common questions of fact, and that centralization under Section 1407 in the Southern District of Illinois will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. All actions share factual questions relating to at least one of the drospirenone-containing oral contraceptives Yaz and Yasmin, which are manufactured by Bayer. Plaintiffs in the products liability actions challenge the safety of those oral contraceptives and bring claims for personal injuries or wrongful death stemming from use of the drugs....

Yaz, Yasmin and Ocella, as well as Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral, have been associated with various serious side effects, including:

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Myocardial Infarction
  • Gallbladder Disease / Injury
  • Gallbladder Removal (cholecystectomy)
  • Death

In essence, the theory of liability being asserted in personal injury and wrongful death lawsuits which have been filed on behalf of women who used Yaz, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral and suffered one of these serious side effects is that the current warnings about those side effects are either insufficient or not shown at all on the package insert, or label, for these birth control pills containing drospirenone (DRSP).

Go to Free Case Evaluation form >>

Read more on our Drospirenone (DRSP) Birth Control Pills Information Page >>

  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535